BOOST Pharma
PrivateLast Round
Convertible Debt
Nov 3, 2025
Total Funding Raised
$6.71M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BOOST Pharma is a clinical-stage biopharmaceutical company that develops novel mesenchymal stem cell therapies for the treatment of rare pediatric skeletal diseases, specifically osteogenesis imperfecta.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BOOST Pharma Comparables
Compare BOOST Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mereo BioPharma Group plc | 77% | |
| Ultragenyx Pharmaceutical Inc. | 71% | |
| AshiBio | 71% | |
BOOST Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Nov 3, 2025 | ||||
| Convertible Debt | Oct 28, 2025 | ||||
| VC Round | May 28, 2024 | ||||
| Grant | Mar 1, 2021 | ||||
| Debt | Feb 1, 2021 | ||||
Pre Seed | Nov 1, 2020 |
Key People
Founding team and executive leadership
BOOST Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Industrifonden | VC Round, Convertible Debt |
| The Export and Investment Fund of Denmark | Debt |
| Karolinska Development AB | VC Round, Convertible Debt |
| BioInnovation Institute | Pre Seed |
| Sound Bioventures | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Grew 55% QoQ from 11 to 17 employees.
- Feb 24, 2026
Grew 71% QoQ from 7 to 12 employees.
BOOST Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BOOST Pharma's valuation, stock price, and market status.